Novo Nordisk
NVO
#18
Rank
C$689.49 B
Marketcap
$156.16
Share price
-0.01%
Change (1 day)
12.55%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Net assets

Net assets on the balance sheet as of June 2024 : C$22.59 Billion

According to Novo Nordisk's latest financial reports the company has C$22.59 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novo Nordisk - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$C$20.93 B28.31%
2022-12-31$C$16.31 B18.85%
2021-12-31$C$13.72 B2.85%
2020-12-31$C$13.34 B18.34%
2019-12-31$C$11.27 B4.24%
2018-12-31$C$10.81 B7.15%
2017-12-31$C$10.09 B17.22%
2016-12-31$C$8.61 B-9.79%
2015-12-31$C$9.54 B25.02%
2014-12-31$C$7.63 B-8.97%
2013-12-31$C$8.38 B17.1%
2012-12-31$C$7.16 B7.96%
2011-12-31$C$6.63 B0.63%
2010-12-31$C$6.59 B-8.96%
2009-12-31$C$7.24 B-4.04%
2008-12-31$C$7.54 B19.98%
2007-12-31$C$6.29 B1.14%
2006-12-31$C$6.22 B22.29%
2005-12-31$C$5.08 B-12.83%
2004-12-31$C$5.83 B5.15%
2003-12-31$C$5.54 B6.08%
2002-12-31$C$5.23 B13.03%
2001-12-31$C$4.62 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$122.72 B 443.14%๐Ÿ‡บ๐Ÿ‡ธ USA
C$19.02 B-15.82%๐Ÿ‡บ๐Ÿ‡ธ USA
C$23.81 B 5.38%๐Ÿ‡บ๐Ÿ‡ธ USA
C$109.16 B 383.11%๐Ÿ‡ซ๐Ÿ‡ท France